Labcorp (LH) vs Oscar Health (OSCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Oscar Health (OSCR) has outperformed Labcorp (LH) over the past year, gaining 51.8% versus a gain of 13.2%. Over five years, OSCR leads with a +108.8% price change compared with +34.7% for LH. Labcorp is the larger company by market cap ($25.62 billion vs $10.23 billion), about 2.5 times the size, while Oscar Health is growing revenue faster (+27.5% vs +7.2%).
On valuation, Oscar Health trades at a lower forward P/E (15.3x vs 16.0x for Labcorp). Labcorp pays a dividend yielding 0.91%, while Oscar Health does not currently pay one. Labcorp converts more of its revenue into profit, with a net margin of 6.3% versus -3.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LH | OSCR |
|---|---|---|
| Share price | $315.93 | $33.15 |
| Market cap | $25.62B | $10.23B |
| 1-day change | +0.55% | +0.15% |
| YTD return | +25.24% | +130.34% |
| 1-year return | +13.22% | +51.83% |
| 5-year return | +34.66% | +108.83% |
| P/E ratio (TTM) | 26.13 | 25.70 |
| Forward P/E | 15.98 | 15.31 |
| EPS (TTM) | $12.09 | $1.29 |
| Dividend yield | 0.91% | 0.00% |
| Annual dividend | $2.88 | $0.00 |
| Revenue (latest FY) | $13.95B | $11.70B |
| Revenue growth (YoY) | +7.25% | +27.50% |
| Net income (latest FY) | $876.50M | $-443.15M |
| Gross margin | 28.76% | — |
| Operating margin | 9.92% | -3.39% |
| Net margin | 6.28% | -3.79% |
| 52-week high | $341.80 | $34.48 |
| 52-week low | $244.52 | $10.69 |
| Distance from 52-week high | -7.57% | -3.86% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +8.95% | +6.79% |
| Average volume | 742.58K | 5.20M |
| Shares outstanding | 81.10M | 273.47M |
| Employees | 71,000 | 2,305 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Labcorp is about 2.5 times larger than Oscar Health by market value ($25.62B vs $10.23B).
- OSCR has outperformed LH by 38.6 percentage points over the past year.
- Labcorp is more profitable, keeping 6.3 cents of every revenue dollar as net income versus -3.8 cents for Oscar Health.
- Oscar Health grew revenue faster in its latest fiscal year (+27.50% vs +7.25%).
About Labcorp
LH stock →Labcorp Holdings Inc. provides laboratory services.
Health Care · Medical Specialities · 71,000 employees
About Oscar Health
OSCR stock →Oscar Health, Inc. operates as a healthcare technology company in the United States.
Health Care · Medical Specialities · 2,305 employees
LH vs OSCR FAQ
Which is bigger, Labcorp or Oscar Health?
Labcorp (LH) is larger, with a market capitalization of $25.62B compared with $10.23B for Oscar Health (OSCR).
Which stock has performed better over the past year, LH or OSCR?
OSCR returned +51.83% over the past 12 months, compared with +13.22% for LH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, LH or OSCR?
OSCR has the lower trailing P/E at 25.7, versus 26.1 for LH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Labcorp or Oscar Health?
Labcorp pays a dividend yielding 0.91%, while Oscar Health does not currently pay a regular dividend.
Are Labcorp and Oscar Health in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.